(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.74%) $81.32
(-1.66%) $1.958
(-0.02%) $2 302.50
(-0.07%) $26.64
(-0.28%) $945.50
(0.06%) $0.938
(0.16%) $11.11
(0.05%) $0.801
(0.00%) $93.45
0.71% $ 1.420
Live Chart Being Loaded With Signals
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections...
Stats | |
---|---|
Volumen de hoy | 706 536 |
Volumen promedio | 13 843.00 |
Capitalización de mercado | 4.55M |
EPS | $-4.50 ( 2023-08-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0722 |
ATR14 | $0.181 (28.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-07-06 | Hogan H Michael Iii | Buy | 0 | |
2023-06-30 | Maggio David | Buy | 0 | |
2023-01-29 | Gelone Steven P. | Sell | 140 | Ordinary Shares |
2023-01-29 | Schroeder Theodore R | Sell | 431 | Ordinary Shares |
2023-01-06 | Gelone Steven P. | Sell | 5 | Ordinary Shares |
INSIDER POWER |
---|
20.49 |
Last 98 transactions |
Buy: 1 927 900 | Sell: 612 376 |
Volumen Correlación
Nabriva Therapeutics PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nabriva Therapeutics PLC Correlación - Moneda/Commodity
Nabriva Therapeutics PLC Finanzas
Annual | 2022 |
Ingresos: | $35.67M |
Beneficio Bruto: | $7.09M (19.87 %) |
EPS: | $-21.32 |
FY | 2022 |
Ingresos: | $35.67M |
Beneficio Bruto: | $7.09M (19.87 %) |
EPS: | $-21.32 |
FY | 2021 |
Ingresos: | $28.90M |
Beneficio Bruto: | $15.75M (54.50 %) |
EPS: | $-96.24 |
FY | 2020 |
Ingresos: | $2.86M |
Beneficio Bruto: | $2.10M (73.25 %) |
EPS: | $-135.23 |
Financial Reports:
No articles found.
Nabriva Therapeutics PLC
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico